SGLT2 Inhibitors
Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy
... drugs. SGLT2-inhibitors increase urinary excretion of glucose by inhibiting its reabsorption via SGLT2 in the proximal tubule of the kidney, thus lowering blood glucose levels ...of SGLT2 ...
12
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
... of SGLT2 inhibitors. For example, as SGLT2 inhibitors cause a modest osmotic diuresis, there may be a risk of hypotension and hypovolemia; although, lowering of blood pressure (BP) may be of ...
46
<p>Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide</p>
... Non-alcoholic fatty liver disease (NAFLD) is de fi ned as fat accumulation in the liver associated with insulin resis- tance and the presence of steatosis in >5% of hepatocytes on histological analysis. This includes ...
12
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
... In another several EMPA-REG OUTCOME trials, patients with T2DM at high risk for CV events who used SGLT2 inhibitors against placebo had a lower rate of the primary composite CV outcome, reduced heart ...
11
The Benefits of SGLT2 Inhibitors in Cardiovascular Prevention, Glycemic Control and Weight Loss, in the Treatment of Diabetes
... co-transporter inhibitors type 2 (SGLT2) comprises a new class of hypog- lycemic drugs to control type 2 diabetes mellitus, in an attempt to add new non-existing benefits to the so far arising ...option, ...
8
SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class
... all SGLT2 inhibitors cautions prescribers to be alert for signs of DKA, which although rare is potentially dangerous and may present atypically (that is, in patients with only moderately increased blood ...
13
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
... It should be noted that this current study did have some limitations, that is, the small number of cases, and the fact that it was not a control study. Since all cases in this study were non-vitreous and after panretinal ...
6
“Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors as a New Class of Anti-diabetic Drugs: Pharmacokinetics, Efficacy and Clinical significance” by Harsharan Pal Singh, Ishpreet Kaur, Gunjan Sharma, India.
... testing. SGLT2 inhibitors are referred to as a chemical inducer of familial renal glucosuria and as an energy controller acting in the negative direction, alongside lifestyle ...principle, SGLT2 ...
8
<p>SGLT2 inhibitors and the changing landscape for treatment of diabetes</p>
... and SGLT2) located in the proximal tubule. 11 SGLT2 is responsible for approximately 90% of glucose reabsorption, while SGLT1 accounts for the remain- ing ...making SGLT2 a logical target in the ...
7
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
... reporting of AKI with only 11 of 111 randomised compar- isons having published data on this outcome. Although an overall protective effect was found, this finding was driven by one large RCT that compared empagliflozin ...
15
Sodium Glucose Co Transporter 2 (SGLT2) Inhibitors in Type 2 Diabetes: A Literature Review of Approved Products
... (SGLT2) inhibitors shows promise in effectively lowering blood glucose in a noninsulin- dependent ...2 inhibitors exert their effect by enhancing renal ...2 inhibitors have also been shown to ...
31
Efficacy and Usefulness of SGLT2 Inhibitors in Niddm Patients on the Backdrop of Metformin and Sulphonyl Urea
... SGLT2 Inhibitors in NIDDM Page 3 Although diabetes has been recognized since antiquity, and treatments of various efficacy have been known in various regions since the Middle Ages, and in legend for much ...
168
The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
... the SGLT2 inhibitors was defined as the drug index date in the SGLT2 inhibitor group, with the same day of the matched non-SGLT2 inhibitor ...of SGLT2 inhibitors (empagliflozin ...
8
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
... (SGLT2) inhibitors, an antidiabetic pharmacologic option has recently become available that comes close to meeting these ...time, SGLT2 inhibitors offer a therapeutic approach acting directly ...
12
TO STUDY THE SAFETY AND EFFICACY OF SGLT2 INHIBITORS AND OTHER ORAL HYPOGLYCAEMIC AGENTS WITH INSULIN IN UNCONTROLLED TYPE 2 DM
... α-glycosidase inhibitors (AGI), thiazolidinediones (TZD), dipeptidyl peptidase-4 inhibitors (DPP4-I) and glucagon-like peptide-1 (GLP-1) ...(SGLT-2) inhibitors were introduced which has more benefits ...
14
Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center
... In conclusion, this real-world study demonstrated the diversity of recent SGLT2i usages with mainly prescribed in long-standing diabetes as a ‘last resort’ therapy before insulin treatment. The durability of glycemic ...
8
<p>Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence</p>
... ter-2 inhibitors; NAFLD, non-alcoholic fatty liver disease; CVD, cardiovascular disease; GLM, glucose-lowering med- ication; SGLT2, sodium-glucose cotransporter-2; CVOT, cardiovascular outcomes trial; MACE, ...
14
Class effects of SGLT2 inhibitors on cardiorenal outcomes
... 4 inhibitors (DPP4i) and canagliflozin was associated with a reduced risk of HHF and a similar risk of MI or stroke compared to DPP4i, glucagon-like peptide-1 agonists, and sulfonylureas [53, ...
13
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
... (SGLT2) inhibitors are a novel class of glucuretic, antihyperglycemic drugs that target the process of renal glucose reabsorption and induce glucuresis independently of insulin secretion or ...mellitus, ...
14
Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition
... SGLT2 Inhibitors and Diabetes Although the possibility of modu- lation of the SGLT2 system via anti-sense molecules is being evalu- ated, the use of SGLT2 inhibitors is much further ...
6